Mantle cell lymphoma: optimizing responses in treatment-naïve and difficult-to-treat patients
Mantle cell lymphoma: optimizing responses in treatmen
Advancing care in Waldenström macroglobulinemia: Clinical and real-world perspectives
Advancing care in Waldenström macroglobulinemia: Clini
Follicular lymphoma: Efficacy and safety updates
Follicular lymphoma: Efficacy and safety updates In
Pushing the boundaries further in the management of CLL
Pushing the boundaries further in the management of CL
Editorial – ASH 2024
Editorial – ASH 2024 Portrait © Uni Klinik U
Economic analysis of zanubrutinib vs. acalabrutinib in B-cell malignancies
Economic analysis of zanubrutinib vs. acalabrutinib in
Relative efficacy of several treatment options in marginal zone lymphoma
Relative efficacy of several treatment options in marg
Follicular lymphoma: news on bispecific antibody treatment
Follicular lymphoma: news on bispecific antibody treat
Innovative BCL2 inhibition: indications fanning out across B-cell malignancies
Innovative BCL2 inhibition: indications fanning
BTK degraders: emerging activity in various B-cell malignancies
BTK degraders: emerging activity in various B-ce
